

Dendrimers have emerged as a powerful class of nanomaterials in the nanomedicine field due to their unique structural features: globular, well-defined, highly branched and controllable structure, nanosize-scale, low polydispersity, and the presence of several terminal groups that can be functionalized with different ligands simulating the multivalency present in different biological systems. Although in its infancy, the application of dendrimers as therapeutics or theranostic tools in central nervous system (CNS) disorders is already significant and has opened promising avenues in the treatment of many conditions where the inherent “smartness” of the dendritic structures is being explored to effectively target the CNS. Here we present an overview of the past and future challenges of the use of dendrimers to respond to one of the ultimate challenges in the (nano)medicine field: to attain CNS repair and regeneration. © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
| Engineering controlled terms: | DendrimersFunctional polymersMedical nanotechnologyNeurodegenerative diseasesNeurophysiology |
|---|---|
| Engineering uncontrolled terms | Blood-brain barrierCell targetingCentral nervous systemsControllable structuresDendritic structuresNeurological diseaseStructural featureSurface Functionalization |
| Engineering main heading: | Neurology |
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Fundação Portugal Telecom | ||
| POCI-01-0145-FEDER-016639,SFRH/BPD/109297/2015,NORTE-01-0145-FEDER-000012,PTDC/CTM-NAN/3547/2014 | ||
| Cosmopolitan Diabetes Foundation See opportunities | ||
| COMPETE 2020 | ||
| European Regional Development Fund | ||
| FIS-2015-01_CCV_20150630-88 | ||
| NORTE 2020 |
V Leiro, SD Santos, and CDF Lopes contributed equally to this work. The authors would like to acknowledge the financial support of the Fundo para a Investiga??o em Sa?de (INFARMED, project reference FIS-2015-01_CCV_20150630-88), as well as the FEDER funds through the Programa Operacional Competitividade e Internacionaliza??o ? COMPETE 2020 and the Portuguese funds through FCT ? Funda??o para a Ci?ncia e a Tecnologia in the frame of the project POCI-01-0145-FEDER-016639 (reference PTDC/CTM-NAN/3547/2014). SD Santos is supported by FCT funds (SFRH/BPD/109297/2015). V Leiro is supported by the project NORTE-01-0145-FEDER-000012, financed by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF).
Paula Pêgo, A.; i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, Portugal;
© Copyright 2018 Elsevier B.V., All rights reserved.